NOXOPHARM LIMITED

ASX: NOX

Sector: Sector:Health Care
Industry group: Industry:Pharmaceuticals, Biotechnology & Life Sciences

Latest NOX ASX Announcements

30 Sept 2026 · 4:05 pmFinancial Results
Audited Financial Statements
30 Sept 20264:05 pmAudited Financial StatementsFinancial Results
14 Sept 2026 · 8:23 amCompany Update
SOF-SKN to progress to extension study in CLE patients
14 Sept 20268:23 amSOF-SKN to progress to extension study in CLE patientsCompany Update
4 Sept 2026 · 8:11 amPresentations
Investor Presentation September 2026
4 Sept 20268:11 amInvestor Presentation September 2026Presentations
1 Sept 2026 · 9:36 amCompany Update
Novel oligonucleotides data presented at Options Conference
1 Sept 20269:36 amNovel oligonucleotides data presented at Options ConferenceCompany Update
28 Aug 2026 · 4:34 pmFinancial Results
Appendix 4E - Preliminary Financial Report
28 Aug 20264:34 pmAppendix 4E - Preliminary Financial ReportFinancial Results
26 Aug 2026 · 8:06 amCompany Update
New preclinical data supports immuno-oncology approach
26 Aug 20268:06 amNew preclinical data supports immuno-oncology approachCompany Update
4 Aug 2026 · 8:18 amCompany Update
New study further validates Noxopharms cancer pipeline
4 Aug 20268:18 amNew study further validates Noxopharms cancer pipelineCompany Update
22 July 2026 · 8:26 amQuarterly Reports
Quarterly Activities/Appendix 4C Cash Flow Report
22 July 20268:26 amQuarterly Activities/Appendix 4C Cash Flow ReportQuarterly Reports
7 July 2026 · 9:34 amCompany Update
Pre-IND meeting request with US FDA
7 July 20269:34 amPre-IND meeting request with US FDACompany Update
2 July 2026 · 8:15 amCompany Update
Sofr platform versatility shown via childbirth MRFF grant
2 July 20268:15 amSofr platform versatility shown via childbirth MRFF grantCompany Update
1 July 2026 · 9:50 amCompany Update
Fast-tracking of cancer program via novel animal model
1 July 20269:50 amFast-tracking of cancer program via novel animal modelCompany Update
9 June 2026 · 8:29 amCompany Update
SOF-SKN manufacturing begins to ensure clinical trial readi
9 June 20268:29 amSOF-SKN manufacturing begins to ensure clinical trial readiCompany Update
1 June 2026 · 4:23 pmDirector Interests
Change of Director's Interest Notice
1 June 20264:23 pmChange of Director's Interest NoticeDirector Interests
26 May 2026 · 8:21 amCompany Update
New data confirms cancer-fighting potential
26 May 20268:21 amNew data confirms cancer-fighting potentialCompany Update
20 May 2026 · 9:21 amCompany Update
Noxopharms Sofra assets to be presented at global conference
20 May 20269:21 amNoxopharms Sofra assets to be presented at global conferenceCompany Update

View complete NOX announcement history →